20-Hydroxy-leukotriene B4
20-Hydroxy-leukotriene B4 is an endogenous metabolite present in Urine that can be used for the research of Sjogren Larsson Syndrome[1][2].
Product Specifications
CAS Number
79516-82-8
Product Name Alternative
20-Hydroxy-LTB4; 20-OH-LTB4
UNSPSC
12352211
Hazard Statement
H225, H319
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/20-hydroxy-leukotriene-b4.html
Solubility
10 mM in DMSO
Smiles
O=C(O)CCC[C@H](O)/C=C\C=C\C=C\[C@H](O)C/C=C\CCCCCO
Molecular Formula
C20H32O5
Molecular Weight
352.47
Precautions
H225, H319
References & Citations
[1]Willemsen MA, et al. Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome. J Neurol Sci. 2001 Jan 15;183 (1) :61-7. |[2]Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39 (35) :5709-5720.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
